1. Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria. Issue 5 (20th May 2023) Authors: Tometten, Mareike; Kirschner, Martin; Meyer, Robert; Begemann, Matthias; Halfmeyer, Insa; Vieri, Margherita; Kricheldorf, Kim; Maurer, Angela; Platzbecker, Uwe; Radsak, Markus; Schafhausen, Philippe; Corbacioglu, Selim; Höchsmann, Britta; Matthias Wilk, C.; Hinze, Claas; Chromik, Jörg; Heuser, Mi... Journal: HemaSphere Issue: Volume 7:Issue 5(2023) Page Start: e874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5‐azacitidine. (20th April 2017) Authors: Radsak, Markus; Platzbecker, Uwe; Schmidt, Cornelia S.; Hofmann, Wolf‐Karsten; Nolte, Florian Journal: European journal of haematology Issue: Volume 99:Number 2(2017) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study. Issue 33 (20th November 2022) Authors: Platzbecker, Uwe; Götze, Katharina S.; Kiewe, Philipp; Germing, Ulrich; Mayer, Karin; Radsak, Markus; Wolff, Thomas; Chromik, Joerg; Sockel, Katja; Oelschlägel, Uta; Haase, Detlef; Illmer, Thomas; Al-Ali, Haifa Kathrin; Silling, Gerda; Reynolds, Joseph G.; Zhang, Xiaosha; Attie, Kenneth M.; Shett... Journal: Journal of clinical oncology Issue: Volume 40:Issue 33(2022) Page Start: 3800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study. Issue 10 (October 2017) Authors: Platzbecker, Uwe; Germing, Ulrich; Götze, Katharina S; Kiewe, Philipp; Mayer, Karin; Chromik, Jörg; Radsak, Markus; Wolff, Thomas; Zhang, Xiaosha; Laadem, Abderrahmane; Sherman, Matthew L; Attie, Kenneth M; Giagounidis, Aristoteles Journal: Lancet oncology Issue: Volume 18:Issue 10(2017:Oct.) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial. Issue 7 (July 2019) Authors: Cortes, Jorge E; Khaled, Samer; Martinelli, Giovanni; Perl, Alexander E; Ganguly, Siddhartha; Russell, Nigel; Krämer, Alwin; Dombret, Hervé; Hogge, Donna; Jonas, Brian A; Leung, Anskar Yu-Hung; Mehta, Priyanka; Montesinos, Pau; Radsak, Markus; Sica, Simona; Arunachalam, Meena; Holmes, Melissa; Ko... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗